Improving HIV treatment for mobile men in Malawi
Reducing Mobility-associated Interruption in ART among Men in Malawi (ReMIT)
['FUNDING_CAREER'] · UNIVERSITY OF CALIFORNIA LOS ANGELES · NIH-11009453
This study is looking to help men living with HIV in Malawi who move around a lot by testing a new way to make it easier for them to stick to their medication, which includes getting their meds for several months at once, having a special hotline for support, and personalized counseling to address their specific needs.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA LOS ANGELES (nih funded) |
| Locations | 1 site (LOS ANGELES, UNITED STATES) |
| Trial ID | NIH-11009453 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the retention of antiretroviral treatment (ART) among mobile men living with HIV in Malawi. It aims to develop and test an intervention that includes multi-month dispensing of medication, a dedicated hotline for support, and counseling tailored to the unique challenges faced by these individuals. By gathering insights from patients, healthcare workers, and community members, the study seeks to create a more effective care model that accommodates the mobility of these men. A pilot trial will assess the intervention's effectiveness and feasibility in real-world settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are men living with HIV in Malawi who frequently move for work or other reasons and struggle to maintain their treatment regimen.
Not a fit: Patients who are not mobile or those who do not have access to ART services may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve ART retention and health outcomes for mobile men living with HIV.
How similar studies have performed: Previous research has shown that tailored interventions can improve treatment adherence among marginalized populations, suggesting potential success for this approach.
Where this research is happening
LOS ANGELES, UNITED STATES
- UNIVERSITY OF CALIFORNIA LOS ANGELES — LOS ANGELES, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: THORP, MARGUERITE — UNIVERSITY OF CALIFORNIA LOS ANGELES
- Study coordinator: THORP, MARGUERITE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome, Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome Virus